Di-iodoacetamide azobenzene was synthesized as previously described.
Briefly, peptide (1.13 mM) was dissolved in Tris·Cl buffer (pH 8) containing Triscarboxyethylphospine (TCEP, 1.13 mM) and incubated at room temperature for two hours. Afterwards, di-iodoacetamide azobenzene was dissolved in DMSO and added to the peptide solution to a final concentration of 0.66 mM. The mixture was placed under foil in a hood with the lights out and allowed to stir for 10 minutes. Afterwards, 56 µl of a 10 mM solution of di-iodoacetamide azobenzene was added to the mixture, and this was allowed to stir in the dark for 10 minutes. Following this, another 56 µl of 10 mM di-iodoacetamide azobenzene was added to the mixture and allowed to stir in the dark for 10 minutes. Then, the mixture was exposed to light and stirred for another 10 minutes.
The mixture was purified using reverse-phase chromatography, and a second round of MALDI spectroscopy was performed to identify the pure labelled compound (i.e., 10b-azob or 10b-h- 
UV-Vis Measurements
UV-Vis spectra were collected on a Lambda 25 UV-Vis spectrometer (Perkin Elmer, MA) using a 1 cm quartz cuvette and an integration time of 0.5 s/nm. Sample concentrations were ~10 µM.
CD Measurements
CD spectra were obtained on an Aviv 62A DS spectropolarimeter (Aviv Associates, NJ) with a 1 mm sample holder. The peptide concentration was in the range of 30-40 µM for the 10b-azob measurements. Trp-cage 10b ∆Hm (kcal mol -1 ) -13.9
62.0
Time-Resolved Measurements
The transient IR setup used is similar to the T-jump IR setup described previously. 2 Briefly, a 3 ns 355 nm pulse derived from a Minilite II Nd:YAG laser (Continuum, CA) was used as the pump, while a continuous wave (CW) quantum cascade (QC) mid-IR laser (Daylight Solutions,
